Vijay Kumar Kuna, Bo Xu, Niclas Kvarnström, Suchitra Sumitran
{"title":"Human blood preconditioned porcine arteries as potential conduits for human transplantation: Proof of concept in rabbit.","authors":"Vijay Kumar Kuna, Bo Xu, Niclas Kvarnström, Suchitra Sumitran","doi":"10.1177/08853282251391312","DOIUrl":null,"url":null,"abstract":"<p><p>Tissue-engineered arteries using natural scaffolds could overcome the drawbacks of autografts or artificial conduits used in the repair of many congenital cardiac defects and coronary artery bypass grafts. In this study, we present a novel approach based on the use of decellularized xenogeneic matrix scaffolds preconditioned with human peripheral blood stem cells for future cardiovascular therapy. Cellular components of porcine carotid arteries (n = 40) were removed with physical, chemical and enzymatic means. The decellularized arteries were preconditioned by perfusion with human peripheral blood solution for 10 days. The decellularized and preconditioned grafts were characterized for their histological and functional integrity. To demonstrate proof-of-concept, we used a sub-acute (96 h) rabbit model where either only decellularized porcine arteries or preconditioned with autologous rabbit blood solution were implanted in the abdominal aorta of the animals. The rabbits were examined by Doppler ultrasound and histology. Histology and molecular analysis showed absence of cells and preservation of extracellular cell matrix (ECM) proteins in decellularized porcine arteries. Preconditioning of arteries with human blood showed a thin lining of intima with blood and cells. In the rabbit implant model, although blood flow was detected in all rabbits at 24 h, the animals implanted with only decellularized arteries showed lumen filled with thrombus. However, in preconditioned arteries, thrombosis was not seen at either 24 or 96 h. Taken together, these results suggest that these decellularization and preconditioning protocols using autologous blood may be adaptable for successful tissue-engineering of xeno-arteries for human application. However, further research to improve preconditioning efficiency and long-term animal studies are needed.</p>","PeriodicalId":15138,"journal":{"name":"Journal of Biomaterials Applications","volume":" ","pages":"1218-1231"},"PeriodicalIF":2.5000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomaterials Applications","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/08853282251391312","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Tissue-engineered arteries using natural scaffolds could overcome the drawbacks of autografts or artificial conduits used in the repair of many congenital cardiac defects and coronary artery bypass grafts. In this study, we present a novel approach based on the use of decellularized xenogeneic matrix scaffolds preconditioned with human peripheral blood stem cells for future cardiovascular therapy. Cellular components of porcine carotid arteries (n = 40) were removed with physical, chemical and enzymatic means. The decellularized arteries were preconditioned by perfusion with human peripheral blood solution for 10 days. The decellularized and preconditioned grafts were characterized for their histological and functional integrity. To demonstrate proof-of-concept, we used a sub-acute (96 h) rabbit model where either only decellularized porcine arteries or preconditioned with autologous rabbit blood solution were implanted in the abdominal aorta of the animals. The rabbits were examined by Doppler ultrasound and histology. Histology and molecular analysis showed absence of cells and preservation of extracellular cell matrix (ECM) proteins in decellularized porcine arteries. Preconditioning of arteries with human blood showed a thin lining of intima with blood and cells. In the rabbit implant model, although blood flow was detected in all rabbits at 24 h, the animals implanted with only decellularized arteries showed lumen filled with thrombus. However, in preconditioned arteries, thrombosis was not seen at either 24 or 96 h. Taken together, these results suggest that these decellularization and preconditioning protocols using autologous blood may be adaptable for successful tissue-engineering of xeno-arteries for human application. However, further research to improve preconditioning efficiency and long-term animal studies are needed.
期刊介绍:
The Journal of Biomaterials Applications is a fully peer reviewed international journal that publishes original research and review articles that emphasize the development, manufacture and clinical applications of biomaterials.
Peer-reviewed articles by biomedical specialists from around the world cover:
New developments in biomaterials, R&D, properties and performance, evaluation and applications
Applications in biomedical materials and devices - from sutures and wound dressings to biosensors and cardiovascular devices
Current findings in biological compatibility/incompatibility of biomaterials
The Journal of Biomaterials Applications publishes original articles that emphasize the development, manufacture and clinical applications of biomaterials. Biomaterials continue to be one of the most rapidly growing areas of research in plastics today and certainly one of the biggest technical challenges, since biomaterial performance is dependent on polymer compatibility with the aggressive biological environment. The Journal cuts across disciplines and focuses on medical research and topics that present the broadest view of practical applications of biomaterials in actual clinical use.
The Journal of Biomaterial Applications is devoted to new and emerging biomaterials technologies, particularly focusing on the many applications which are under development at industrial biomedical and polymer research facilities, as well as the ongoing activities in academic, medical and applied clinical uses of devices.